144
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Predictors of Glucocorticoid Use for Acute Optic Neuritis in the United States, 2005-2019

, , , , , & show all
Pages 88-94 | Received 03 Jul 2021, Accepted 21 Jan 2022, Published online: 16 Feb 2022

References

  • Beck RW, Cleary PA, Anderson MM Jr., et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The optic neuritis study group. New Engl J Med. 1992;326(9):581–588. doi:10.1056/NEJM199202273260901.
  • Hassan MB, Stern C, Flanagan EP, et al. Population-based incidence of optic neuritis in the era of aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies. Am J Ophthalmol. 2020;220:110–114. doi:10.1016/j.ajo.2020.07.014.
  • Beck RW, Cleary PA. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol. 1993;111(6):773–775. doi:10.1001/archopht.1993.01090060061023.
  • Beck RW, Cleary PA, Backlund JC. The course of visual recovery after optic neuritis. Experience of the optic neuritis treatment trial. Ophthalmol. 1994;101(11):1771–1778. doi:10.1016/S0161-6420(94)31103-1.
  • Biousse V, Calvetti O, Drews-Botsch CD, et al. Management of optic neuritis and impact of clinical trials: an international survey. J Neurol Sci. 2009;276(1–2):69–74. doi:10.1016/j.jns.2008.08.039.
  • Meer E, Shindler KS, Yu Y, and VanderBeek BL. Adherence to clinical trial supported evaluation of optic neuritis. Ophthalmic Epidemiol. 2019;26(5):1–8.
  • Marrie RA, Ekuma O, Wijnands JMA, et al. Identifying optic neuritis and transverse myelitis using administrative data. Mult Scler Relat Disord. 2018;25:258–264. doi:10.1016/j.msard.2018.08.013.
  • Schimmer BP, Funder W. Adrenocorticotropic Hormone, Adrenal Steroids, and the Adrenal Cortex. In: Brunton LL, Hilal-Dandan R, Knollmann BC, eds. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 13e. McGraw-Hill; 2017. Accessed 31 Jan 2022. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=2189&sectionid=172482605
  • Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977;63(2):200–207. doi:10.1016/0002-9343(77)90233-9.
  • Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.83.
  • Hamedani AG, De Lott LB, Deveney T, Moss HE. Validity of international classification of diseases codes for identifying neuro-ophthalmic disease in large data sets: a systematic review. J Neuroophthalmol. 2020;40(4):514–519. doi:10.1097/WNO.0000000000000971.
  • Winthrop KL, Chen L, Fraunfelder FW, et al. Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study. Am J Ophthalmol. 2013;155(1):183–189 e181. doi:10.1016/j.ajo.2012.06.023.
  • Waljee AK, Rogers MA, Lin P, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415. doi:10.1136/bmj.j1415.
  • Yao TC, Huang YW, Chang SM, Tsai SY, Wu AC, Tsai HJ. Association between oral corticosteroid bursts and severe adverse events: a nationwide population-based cohort study. Ann Intern Med. 2020;173(5):325–330. doi:10.7326/M20-0432.
  • Horton L, Bennett JL. Acute management of optic neuritis: an evolving paradigm. J Neuroophthalmol. 2018;38(3):358–367. doi:10.1097/WNO.0000000000000700.
  • Chen JJ, Bhatti MT. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Curr Opin Neurol. 2020;33(1):47–54. doi:10.1097/WCO.0000000000000766.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.